| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | Jun 25, 2025 | Terns Pharmaceuticals, Inc. | CEO | Buy | 95.0 | +23,314 | 98.09% | ✗ | $90.2K |
| Nov 30, 2024 | Feb 3, 2025 | Terns Pharmaceuticals, Inc. | CEO | Buy | 82.5 | +510 | 2.67% | ✗ | $2.6K |
| Dec 5, 2024 | Dec 9, 2024 | Terns Pharmaceuticals, Inc. | CEO | Buy | 95.0 | +15,450 | 423.40% | ✗ | $110.5K |
| Aug 16, 2021 | Aug 17, 2021 | DiaMedica Therapeutics Inc. | Director | Buy | 95.0 | +44,950 | 100.00% | ✗ | $141.6K |